Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Cognitive Control clinical trials

1 of 3 indexed Cognitive Control trials are currently recruiting.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Cognitive Control: 3 US clinical trials tracked, 1 recruiting.

Cognitive Control is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Florida International University, running 1 of these trials.

Enrollment posture brief

Registry condition cognitive-control

OPEN 1 | RECR 33% | LATE 0 | EARLY 0 | RANK #5209 | SPON 1

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Cognitive Control (this)33%
Open-enrollment share among volume-matched conditions near Cognitive Control

Cognitive Control lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cognitive Control on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cognitive Control is recruiting below its size-band peers.

    1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Cognitive Control records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Delta-beta tACS Device
1 trials
Theta-gamma tACS Device
1 trials
cTBS then iTBS Device
1 trials
iTBS then cTBS Device
1 trials
STARSTIM Device anti-phase Device
1 trials
STARSTIM Device in-phase Device
1 trials
Sham device Device
1 trials
Sham tACS Device
1 trials

US sites by state

Facility locations filed on Cognitive Control trials. A trial with sites in several states counts in each.

North Carolina 1 trials
Florida 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cognitive Control page

3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cognitive Control condition card totals 3 registered trials; most-linked intervention Delta-beta tACS; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.